• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Effect of endothelin receptor antagonist on the liver graft

Research Project

Project/Area Number 08671496
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionFirst Department of Surgery, Hyogo College of Medicine

Principal Investigator

YAMANAKA Naoki  Hyogo College of Medicine, First Department of Surgery, Associated Professor, 医学部, 助教授 (90131599)

Co-Investigator(Kenkyū-buntansha) SASAKI Sadao  Associated Professor, 医学部, 助教授 (20104276)
YAMANAKA Junichi  Assistant Professor, 医学部, 助手 (90289083)
YASUI Chiaki  Assistant Professor, 医学部, 助手 (10291816)
TANAKA Tsuneo  Assistant Professor, 医学部, 助手 (80248137)
OKAMOTO Eizo  Professor, 医学部, 教授 (50068425)
Project Period (FY) 1996 – 1998
KeywordsLiver ischemia reperfusion injury / Endothelin receptor antagonist / Endothelin-1 / Liver transplantation / Intracellular element / Liver graft function
Research Abstract

One of the vasoconstrictive substances is endothelin-l (ET-l) that was isolated from the culture supernatant of vascular endothelial cells. First, dynamics of ET-l and its implication in the pathogenesis of liver ischemia-reperfusion injury was investigated. As a result, the ET-i released from the vascular endothelium, including the liver and the portal bed, was found to be a possible factor of ischemia-reperfusion injury (Ref. 1). Second, hepatoprotective effect of the endothelin receptor antagonist, TAK-044, against ischemia-reperfusion injury was investigated in the canine partial liver ischemic model. This study demonstrated that hepatic microcirculatory disturbance, tissue injury and elevation of portal pressure during and after inflow occlusion was significantly suppressed in the TAK-044 treated group (2). Better stability of the intracellular elements (Ca, Na, Cl, K) and better preservation of morphologic architecture after reperfusion was also obtained in the treated group (2, 3). This hepatoprotective effect was revealed not only in the normal rat liver but also in the cirrhotic liver (4). Third, a similar study was conducted using a liver transplanted graft. Rat transplantation model showed that optimal administration route of endothelin receptor antagonist for the graft protection was not intravenous injection but intraportal injection along with rinse solution.
In reality, in a porcine transplantation model, better graft protection after recirculation was obtained in the treated animals in the aspect of the liver functions, microcirculation and intracellular elemental dynamics (5). These studies lead to the conclusion that ET-1 plays an important role in the pathogenesis of ischemia-reperfusion injury, and that supplementary use of the endothelin receptor antagonist prior to ischemia may contribute to hepatoprotection in a clinical setting of hepatic inflow occlusion during hepatectomy or liver transplantation.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 高屋豊: "ブタ同所性肝移植における移植肝細胞内元素分析" 今日の移植. 8(6). 619-624 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 河村英輔: "Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury" Hepatology. 21(4). 1138-1143 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 北山佳弘: "Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the liver" Hepatology. 25(4). 938-942 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山中若樹: "Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver" Journal of Surgical Research. 70. 156-160 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 今北正道: "Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alterations in the ischemic-reperfused liver in Beagle dogs" Journal of Hepatology. 28. 204-211 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 北山佳弘: "Hepatoprotective effect of the endotheline receptor antagonist TAK-044 ischemia-reperfusion injury in the cirrhotic rat liver" Hepatology Research. 13. 1-9 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawamura E.: "Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury." Hepatology. 21. 1138-1143 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamanaka N.: "Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver." Journal of Surgical Research. 70. 156-160 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitayama Y.: "Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver." Hepatology. 25. 938-942 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitayama Y.: "Hepatoprotective effect of the endothelin receptor antagonist TAK-044 ischemia-reperfusion injury in the cirrhotic rat liver." Hepatology Research. 13. 1-9 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Imakita M.: "Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alterations in the ischemic-reperfused liver in Beagle dogs." Journal of Hepatology. 28. 204-211 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuroda N.: "Dynamics of Portal and peripheral endothelin-1 in hepatic resection and its implication." Journal of Surgical Research. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi